Peak metamorphic temperatures in the Alpine tectonic wedge, south Cottian Alps, Italy

Autor: Lahfid, Abdeltif, Michard, André, Chopin, Christian, Schmid, S.M., Dana, D., Ballèvre, Michel

Publikováno v: Abstract book
CONGRESSO SGI-SIMP 2022
CONGRESSO SGI-SIMP 2022, Società Geologica Italiana, Sep 2022, Torino, Italy. pp.321
Congresso SGI SIMP (Torino 2022)
Congresso SGI SIMP (Torino 2022), Sep 2022, TURIN, Italy.

International audience; In the south Cottian Alps, the metamorphic wedge of the Western Alps is widely exposed. It includes, fromSW to NE, the Briançonnais internal border (Acceglio units), the ophiolitic Schistes lustrés nappes (Piemonte-Liguria O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::34db20dc7a05d2019705b412433e0288
https://insu.hal.science/insu-03788129

Disease-related surgery in patients with distant metastatic breast cancer

Autor: Amann, E., Huang, D.J., Weber, W.P., Eppenberger-Castori, S., Schmid, S.M., Hess, T.H., Güth, U.

Publikováno v: In European Journal of Surgical Oncology November 2013 39(11):1192-1198

Increasing rates of contralateral prophylactic mastectomy – A trend made in USA?

Autor: Güth, U., Myrick, M.E., Viehl, C.T., Weber, W.P., Lardi, A.M., Schmid, S.M.

Publikováno v: In European Journal of Surgical Oncology April 2012 38(4):296-301

Sentinel lymph node biopsy in primary breast cancer: Trust the radiolabeled colloid method and avoid unnecessary procedures

Autor: Schmid, S.M., Myrick, M.E., Forrer, F., Obermann, E.C., Viehl, C.T., Rochlitz, C., Güth, U.

Publikováno v: In European Journal of Surgical Oncology March 2011 37(3):211-216

Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

Autor: Aberle, J., Menzen, M., Schmid, S.M., Terkamp, C., Jaeckel, E., Rohwedder, K., Scheerer, M.F., Xu, J., Tang, W., Birkenfeld, A.L.

Publikováno v: Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Sci. Rep. 10:22396 (2020)

Recent studies have shown that high-risk patients with type 2 diabetes mellitus (T2DM) treated with sodium glucose cotransporter 2 (SGLT2) inhibitors have improved cardiovascular (CV) outcomes. In an exploratory analysis of data from the EMPA-REG stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3b5d0f27b8276534a456b0463f7316e9
http://europepmc.org/articles/PMC7769973